Long COVID symptoms can persist for years, with slim chance of full recovery Funding and attention for long COVID research are dwindling in many wealthy ...

Background: Antiphospholipid antibodies (aPL) trigger inflammation, vasculopathy, and thrombosis, sharing pathophysiological mechanisms with atherosclerosis. However, their association with incident ...

Objectives: This is a critical review of anti-phospholipid antibodies (aPL). Most prior reviews focus on the aPL syndrome (APS), a thrombotic condition often marked by neurological disturbance.

Most people with lupus have antinuclear antibodies (ANAs) in their blood. But a positive ANA test doesn’t always mean lupus. The test can be positive in people with other autoimmune illnesses — ...

UCB has yet to finalize its plans for the antibody, but the team behind the drug hopes to test it in future trials. Roche had licensed the rights to bepranemab for US$120 million, in 2020 ...